DONEGAL MUTUAL INSURANCE CO purchased $381K of DGICA

DONEGAL MUTUAL INSURANCE CO purchased 20,000 shares of DONEGAL GROUP INC (DGICA) at an average of $19.07 ($18.95–$19.19, $0.38M total) across 2 trades over 2026-08-27 to 2026-08-28.

Original reporting
SEC EDGAR · DONEGAL MUTUAL INSURANCE CO
Published Aug 31, 2026, 1:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 3:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
high confidence
Mentioned
$DGICA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

The purchase adds ~0.14% to the insider's holdings, unlikely to move the stock.

02

Market read

Limited relevance; primarily informational for compliance tracking.

03

What to watch

Potential future purchases or hidden strategic interest not evident from this single filing.

Relevance 5/10Novelty 4/10Timing: filing today

Background

Form 4 filings disclose insider transactions; this filing reports a modest purchase by an insurance subsidiary.

Company-level read

Ticker impact

$DGICANeutralHigh confidence
Context

Donegal Mutual Insurance Co purchased 20,000 shares of Donegal Group Inc for $381,450 via a Form 4 filing.

Expected impact

No significant move expected.

Evidence & confidence

The transaction size is modest relative to the company's market cap and shares outstanding.

Market effects

None

None

None

Counterpoint

Even small insider buys can signal confidence, but size is too low to act on.

Key entities

  • Donegal Mutual Insurance Co

    Purchaser of the shares.

  • Donegal Group Inc

    Company whose shares were bought.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o